1,2,3,4-tetrahydroisoquinoline has been researched along with levodopa in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yoshida, M | 1 |
Bystritsky, A; Engel, J; Goldstein, M; Passeltiner, P; Rabey, JM | 1 |
Armando, I; Clow, A; Glover, V; Sandler, M | 1 |
Nagatsu, T; Ogawa, M; Suzuki, K; Yoshida, M | 1 |
Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T | 1 |
5 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and levodopa
Article | Year |
---|---|
[Tetrahydroisoquinoline and parkinsonism].
Topics: Animals; Chemical Phenomena; Chemistry; Female; Isoquinolines; Levodopa; Male; Mice; Motor Activity; Parkinson Disease, Secondary; Saimiri; Tetrahydroisoquinolines | 1989 |
The regulation of striatal DOPA synthesis by alpha 2-adrenoreceptors.
Topics: Adrenergic beta-Antagonists; Animals; Corpus Striatum; Dopamine; Isoquinolines; Levodopa; Male; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Dopamine; Tetrahydroisoquinolines | 1981 |
Pictet-Spengler condensation products, stress and alcoholism: some clinical overtones.
Topics: Alcoholism; Animals; Carbolines; Chemical Phenomena; Chemistry; Gas Chromatography-Mass Spectrometry; Humans; Isoquinolines; Levodopa; Monoamine Oxidase Inhibitors; Papaverine; Rats; Salsoline Alkaloids; Stress, Physiological; Substance Withdrawal Syndrome; Tetrahydroisoquinolines; Tetrahydropapaveroline | 1982 |
Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues.
Topics: Animals; Biopterins; Caudate Nucleus; Dopamine; Female; Isoquinolines; Levodopa; Male; Neurons; Parkinson Disease, Secondary; Putamen; Saimiri; Structure-Activity Relationship; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 1993 |
Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carbidopa; Cell Count; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypokinesia; Immunohistochemistry; Isoquinolines; Levodopa; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Serotonin; Stereoisomerism; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 2001 |